StellarOne Corp’s GSK GSK Stock Holding History

StellarOne Corp’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$35K	Hold	562	–	–	0.03%	114
2013 Q2	$35K	Buy	+562	New	+$35.7K	0.03%	109

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

StellarOne Corp's GSK Position: Q3 2013 in Review

StellarOne Corp held its GSK (GSK) position steady in Q3 2013 at 562 shares worth $35K. The position accounts for 0.03% of the portfolio, ranked #114.

StellarOne Corp first reported a position in GSK in Q2 2013 and has held it in 2 quarters since. 635 funds tracked by Wall St. Rank hold GSK as of Q3 2013.

StellarOne Corp held 562 shares of GSK worth $35K as of Q3 2013.
StellarOne Corp left its GSK share count unchanged in Q3 2013.
GSK made up 0.03% of StellarOne Corp's portfolio in Q3 2013, its #114 holding.
StellarOne Corp first reported a position in GSK in Q2 2013 and has held it in 2 quarters since.
635 funds tracked by Wall St. Rank held GSK as of Q3 2013.

Based on StellarOne Corp's 13F filing for Q3 2013, filed 12 Nov 2013.